 |
 |
|
||
    |
Integrating EHS Activities With Lilly New Product DevelopmentProduct stewardship - the passage of a new pharmaceutical from discovery through development to launch - takes many forms. One of the most important forms at Lilly is the environmental, health and safety efforts that help bring a new product to market. We believe that identifying, evaluating and integrating EHS issues into a product's development at the earliest stages of its life cycle enhances our EHS performance and makes good business sense.Under the New Product Environmental Requirements Tracking (NPERT) process, environmental issues are identified and addressed from the very beginning. The NPERT process mandates that the Pharmaceutical Process Development team (PPD team) identify and quantify the raw materials used and the wastes generated at each process step. The PPD team uses the waste management hierarchy to determine how best to minimize the waste generated in the manufacturing process, giving priority to source reduction, then recycling, and so on. The PPD team identifies the hazards and the difficulties in treating the waste associated with the raw materials and processing to determine if chemical substitutions are desirable and possible. If a substitute is not possible, then consideration is given to recycling, treatment, and ultimately disposal.
|
|||
